The ferroptosis inducer erastin irreversibly inhibits system x<sub>c</sub>- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells.
Sato M, Kusumi R, Hamashima S, Kobayashi S, Sasaki S, Komiyama Y, Izumikawa T, Conrad M, Bannai S, Sato H. · 2018
Read The ferroptosis inducer erastin irreversibly inhibits system x<sub>c</sub>- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells. by Sato M, Kusumi R, Hamashima S, Kobayashi S, Sasaki S, Komiyama Y, Izumikawa T, Conrad M, Bannai S, Sato H. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5772355.txt.
Description
Sato and co-authors probe how erastin, a ferroptosis trigger, blocks a cell transporter. The transporter, system xc minus, feeds cells the raw stuff for a key antioxidant. Erastin was known to shut it, but the manner was unclear. The team compared erastin with known blockers in cancer cells.
Erastin proved the strongest blocker at low doses, they report. A brief exposure shut the transporter for a long time and drained the antioxidant. The block did not rest on changes to the transporter itself. Short erastin treatment also made cisplatin far more deadly to tumor cells.
Catalog record
| CREATOR | Sato M, Kusumi R, Hamashima S, Kobayashi S, Sasaki S, Komiyama Y, Izumikawa T, Conrad M, Bannai S, Sato H. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |